Work can make you mentally ill, but we still have a lot to learn about the links between employment and mental health

stress-704402_640

Chris O’Sullivan explores a recent systematic meta-review of work-related risk factors for common mental health problems.

[read the full story...]

Job clubs may protect unemployed people from depression

8214124711_f43b2671ab_k

Ian Cummins explores a recent systematic review of interventions to reduce the impact of unemployment and economic hardship on mental health in the general population.

[read the full story...]

Cochrane find insufficient evidence to support the implementation of depression prevention programmes

no-freedom-1886980_640

Ioana Cristea summarises the latest Cochrane review on CBT, third-wave CBT and IPT based interventions for preventing depression in children and adolescents

[read the full story...]

Peer support for physical health improvement: recovering ‘stolen years’?

suicide-1267709_640

Lucy Simons discusses whether peer support interventions can help to provide physical health improvements for people living with severe mental illness.

[read the full story...]

Anti-stigma programmes should target personal attitudes towards mental health #TimeToTalk

6840797051_244790e11d_o

Today is #TimeToTalk Day, so we’ve asked Kirsten Lawson to consider a brand new systematic review out today, which explores the association between mental health-related stigma and active help-seeking.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

In search of the sweet spot: the links between dysglycaemia and first episode psychosis

lump-sugar-549096_1280

Ben Perry publishes his debut blog on a recent systematic review of impaired glucose homeostasis in first-episode schizophrenia.

[read the full story...]

Risperidone versus placebo for people with schizophrenia

14397363653_f60cbb91b2_k

Joanne Wallace summarises the recent Cochrane systematic review on risperidone versus placebo for schizophrenia, which concludes that the best available evidence does not show that the benefits of risperidone outweigh the harms.

[read the full story...]